Tourmaline Bio Earnings Estimate
| TRML Stock | 21.33 0.61 2.78% |
Tourmaline | Build AI portfolio with Tourmaline Stock |
Tourmaline Bio Earnings Estimation Breakdown
The calculation of Tourmaline Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Tourmaline Bio is estimated to be -0.9313 with the future projection ranging from a low of -1.05 to a high of -0.78. Please be aware that this consensus of annual earnings estimates for Tourmaline Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.05 Lowest | Expected EPS | -0.78 Highest |
Tourmaline Bio Earnings Projection Consensus
Suppose the current estimates of Tourmaline Bio's value are higher than the current market price of the Tourmaline Bio stock. In this case, investors may conclude that Tourmaline Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Tourmaline Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2025 | Current EPS (TTM) | |
| 11 | 84.52% | -0.89 | -0.9313 | -3.23 |
Tourmaline Bio Earnings per Share Projection vs Actual
Actual Earning per Share of Tourmaline Bio refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Tourmaline Bio predict the company's earnings will be in the future. The higher the earnings per share of Tourmaline Bio, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Tourmaline Bio Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Tourmaline Bio, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Tourmaline Bio should always be considered in relation to other companies to make a more educated investment decision.Tourmaline Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Tourmaline Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-12 | 2025-03-31 | -0.9363 | -0.89 | 0.0463 | 4 | ||
2025-03-17 | 2024-12-31 | -0.87 | -0.86 | 0.01 | 1 | ||
2024-11-12 | 2024-09-30 | -0.82 | -0.78 | 0.04 | 4 | ||
2024-08-08 | 2024-06-30 | -0.71 | -0.68 | 0.03 | 4 | ||
2024-05-13 | 2024-03-31 | -0.67 | -0.55 | 0.12 | 17 | ||
2024-03-19 | 2023-12-31 | -0.79 | -0.81 | -0.02 | 2 | ||
2023-11-14 | 2023-09-30 | -0.6 | -1.6421 | -1.0421 | 173 | ||
2023-08-10 | 2023-06-30 | -0.2 | -3.4947 | -3.2947 | 1647 | ||
2023-05-11 | 2023-03-31 | -0.455 | -0.37 | 0.085 | 18 | ||
2023-03-16 | 2022-12-31 | -0.49 | -5.2 | -4.71 | 961 | ||
2022-11-10 | 2022-09-30 | -0.454 | -4.6 | -4.146 | 913 | ||
2022-08-15 | 2022-06-30 | -0.455 | -4.4 | -3.945 | 867 | ||
2022-05-12 | 2022-03-31 | -0.3833 | -4.5 | -4.1167 | 1074 | ||
2022-03-17 | 2021-12-31 | -0.3767 | -3.5 | -3.1233 | 829 | ||
2021-11-12 | 2021-09-30 | -0.35 | -3.2 | -2.85 | 814 | ||
2021-08-12 | 2021-06-30 | -0.26 | -4.1 | -3.84 | 1476 | ||
2021-06-02 | 2021-03-31 | -0.7733 | -13.0 | -12.2267 | 1581 | ||
2021-03-03 | 2020-12-31 | 0 | -0.16 | -0.16 | 0 |
About Tourmaline Bio Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Tourmaline Bio earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Tourmaline Bio estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Tourmaline Bio fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -135.3 M | -128.5 M | |
| Earnings Yield | (0.14) | (0.15) | |
| Price Earnings Ratio | (7.02) | (7.37) | |
| Price Earnings To Growth Ratio | 0.10 | 0.10 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.